Boxer Capital, Llc - Net Worth and Insider Trading
Boxer Capital, Llc Net Worth
The estimated net worth of Boxer Capital, Llc is at least $738 Million dollars as of 2024-11-05. Boxer Capital, Llc is the of Mirati Therapeutics Inc and owns about 6,672,789 shares of Mirati Therapeutics Inc (MRTX) stock worth over $392 Million. Boxer Capital, Llc is the 10% Owner of Pandion Therapeutics Inc and owns about 2,131,135 shares of Pandion Therapeutics Inc (PAND) stock worth over $128 Million. Boxer Capital, Llc is also the 10% Owner of Tyra Biosciences Inc and owns about 6,448,359 shares of Tyra Biosciences Inc (TYRA) stock worth over $105 Million. Besides these, Boxer Capital, Llc also holds Tango Therapeutics Inc (TNGX) , ITeos Therapeutics Inc (ITOS) , Odonate Inc (ODTC) , PMV Pharmaceuticals Inc (PMVP) , Esperion Therapeutics Inc (ESPR) , Rain Oncology Inc (RAIN) , Solid Biosciences Inc (SLDB) , Aradigm Corp (ARDMQ) , Sophiris Bio Inc (SPHS) . Details can be seen in Boxer Capital, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Boxer Capital, Llc has not made any transactions after 2023-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Boxer Capital, Llc
Boxer Capital, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Boxer Capital, Llc owns 14 companies in total, including Odonate Inc (ODTC) , PMV Pharmaceuticals Inc (PMVP) , and ITeos Therapeutics Inc (ITOS) among others .
Click here to see the complete history of Boxer Capital, Llc’s form 4 insider trades.
Insider Ownership Summary of Boxer Capital, Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ODTC | Odonate Inc | 2021-11-24 | director & 10 percent owner |
PMVP | PMV Pharmaceuticals Inc | 2020-09-25 | 10 percent owner |
ITOS | ITeos Therapeutics Inc | 2023-08-23 | other: See remarks |
2020-07-21 | 10 percent owner | ||
2023-08-11 | other: See remarks | ||
2019-03-28 | 10 percent owner | ||
2018-11-05 | 10 percent owner | ||
2016-06-02 | 10 percent owner | ||
2014-12-15 | 10 percent owner | ||
2013-05-20 | 10 percent owner | ||
2023-05-22 | other: See remarks. | ||
2023-10-16 | other: See remarks | ||
2021-12-17 | 10 percent owner | ||
2016-06-02 | 10 percent owner |
Boxer Capital, Llc Latest Holdings Summary
Boxer Capital, Llc currently owns a total of 12 stocks. Among these stocks, Boxer Capital, Llc owns 6,672,789 shares of Mirati Therapeutics Inc (MRTX) as of August 11, 2023, with a value of $392 Million and a weighting of 53.09%. Boxer Capital, Llc owns 2,131,135 shares of Pandion Therapeutics Inc (PAND) as of July 21, 2020, with a value of $128 Million and a weighting of 17.35%. Boxer Capital, Llc also owns 6,448,359 shares of Tyra Biosciences Inc (TYRA) as of December 17, 2021, with a value of $105 Million and a weighting of 14.22%. The other 9 stocks Tango Therapeutics Inc (TNGX) , ITeos Therapeutics Inc (ITOS) , Odonate Inc (ODTC) , PMV Pharmaceuticals Inc (PMVP) , Esperion Therapeutics Inc (ESPR) , Rain Oncology Inc (RAIN) , Solid Biosciences Inc (SLDB) , Aradigm Corp (ARDMQ) , Sophiris Bio Inc (SPHS) have a combined weighting of 15.35% among all his current holdings.
Latest Holdings of Boxer Capital, Llc
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MRTX | Mirati Therapeutics Inc | 2023-08-11 | 6,672,789 | 58.70 | 391,692,714 |
PAND | Pandion Therapeutics Inc | 2020-07-21 | 2,131,135 | 60.05 | 127,974,657 |
TYRA | Tyra Biosciences Inc | 2021-12-17 | 6,448,359 | 16.27 | 104,914,801 |
TNGX | Tango Therapeutics Inc | 2023-10-16 | 15,912,577 | 5.10 | 81,074,580 |
ITOS | ITeos Therapeutics Inc | 2023-08-23 | 1,804,058 | 8.93 | 16,110,238 |
ODTC | Odonate Inc | 2021-11-24 | 421 | 17,050.00 | 7,178,050 |
PMVP | PMV Pharmaceuticals Inc | 2020-09-25 | 2,329,073 | 1.63 | 3,796,389 |
ESPR | Esperion Therapeutics Inc | 2018-11-05 | 1,101,250 | 2.08 | 2,292,032 |
RAIN | Rain Oncology Inc | 2023-05-22 | 1,152,212 | 1.21 | 1,394,177 |
SLDB | Solid Biosciences Inc | 2019-03-28 | 231,552 | 5.73 | 1,326,793 |
ARDMQ | Aradigm Corp | 2013-05-20 | 1,354,425 | 0.05 | 62,304 |
SPHS | Sophiris Bio Inc | 2014-12-15 | 161,447 | 0.00 | 16 |
Holding Weightings of Boxer Capital, Llc
Boxer Capital, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Boxer Capital, Llc has made a total of 5 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 3 buys and 2 sells. The most-recent trade in Mirati Therapeutics Inc is the acquisition of 1,258,973 shares on August 11, 2023, which cost Boxer Capital, Llc around $35 Million.
According to the SEC Form 4 filings, Boxer Capital, Llc has made a total of 1 transactions in Pandion Therapeutics Inc (PAND) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pandion Therapeutics Inc is the acquisition of 722,222 shares on July 21, 2020, which cost Boxer Capital, Llc around $13 Million.
According to the SEC Form 4 filings, Boxer Capital, Llc has made a total of 2 transactions in Tyra Biosciences Inc (TYRA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Tyra Biosciences Inc is the acquisition of 125,000 shares on December 17, 2021, which cost Boxer Capital, Llc around $2 Million.
More details on Boxer Capital, Llc's insider transactions can be found in the Insider Trading History of Boxer Capital, Llc table.Insider Trading History of Boxer Capital, Llc
- 1
Boxer Capital, Llc Trading Performance
GuruFocus tracks the stock performance after each of Boxer Capital, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Boxer Capital, Llc is 15.46%. GuruFocus also compares Boxer Capital, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Boxer Capital, Llc within 3 months outperforms 17 times out of 28 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Boxer Capital, Llc's insider trading performs compared to the benchmark.
Performance of Boxer Capital, Llc
Boxer Capital, Llc Ownership Network
Ownership Network List of Boxer Capital, Llc
Ownership Network Relation of Boxer Capital, Llc
Boxer Capital, Llc Owned Company Details
What does Odonate Inc do?
Who are the key executives at Odonate Inc?
Boxer Capital, Llc is the director & 10 percent owner of Odonate Inc. Other key executives at Odonate Inc include 10 percent owner Ecor1 Capital, Llc , director & 10 percent owner & Chief Executive Officer Kevin C Tang , and director & 10 percent owner Aaron I. Davis .
Odonate Inc (ODTC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Odonate Inc (ODTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Odonate Inc (ODTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Odonate Inc (ODTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Odonate Inc Insider Transactions
Boxer Capital, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Boxer Capital, Llc. You might contact Boxer Capital, Llc via mailing address: 12860 El Camino Real, Suite 300, San Diego Ca 92130.